Top Glucagon like Peptide 1 Agonists Companies in North America

  1. AstraZeneca

  2. Sanofi

  3. Eli Lilly and Company

  4. Pfizer

  5. Novo Nordisk

*Disclaimer: Top companies sorted in no particular order

North America Glucagon-like Peptide-1 Agonists Market Major Players

North America Glucagon-like Peptide-1 Agonists - Competitive Concentration

North America Glucagon-like Peptide-1 Agonists Market Concentration

List of Glucagon like Peptide 1 Agonists Companies in North America

  • Adocia SA

  • Amgen

  • AstraZeneca

  • Boehringer Ingelheim

  • Biocon Ltd

  • Eli Lilly and Company

  • Hanmi Pharmaceutical Co. Ltd.

  • Innovent Biologics Inc.

  • Altimmune Inc

  • Merck

  • Novo Nordisk

  • Pfizer

  • Rhythm Pharmaceuticals Inc.

  • Roche

  • Sanofi

  • Takeda Pharmaceuticals

  • Samsung Bioepis

  • Viking Therapeutics Inc.

  • Xeris Biopharma Holdings Inc.

  • Zealand Pharma

Get more insights on North America Glucagon-like Peptide-1 Agonists industry from our comprehensive report